# Inhibikase Therapeutics, Inc.: Form DEF 14A, filed Nov 18, 2024

- Company: [Inhibikase Therapeutics, Inc.](/companies/ikt.md) (CIK 1750149)
- Form: DEF 14A
- Filed: 2024-11-18
- Accepted by EDGAR: Nov 18, 2024, 21:05 ET
- Period: 2025-01-03
- Accession: 0000950170-24-127941
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1750149/000095017024127941/ikt-20241118.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750149/000095017024127941/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750149/000095017024127941/ikt-20241118.htm

Filed Nov 18, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-127941. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.